About the Company

[Summary] Top 100 Enterprise in China's Pharmaceutical Industry

Shandong Lukang Pharmaceutical Co., Ltd. (referred to as Lukang Pharmaceutical) is located in Jining City, Shandong Province. Established in 1966, it is a large state-controlled comprehensive pharmaceutical enterprise. It was listed on the main board in 1997 (stock abbreviation: Lukang Pharmaceutical, stock code: 600789).
The company has total assets of 6.6 billion yuan, over 6,000 employees, and 13 affiliated enterprises, including 5 wholly-owned subsidiaries, 6 holding subsidiaries, and 2 equity-participated companies. Qinghai Dadi Company is a production base for Chinese and Tibetan medicines, Tai'an Saite Company is a production base for non-penicillin and non-cephalosporin preparations, and Qihe Bio-pesticide Company is a bio-pesticide production base.
Lukang Pharmaceutical's main products include human APIs and preparations, animal and plant drugs, covering more than 500 varieties including anti-infective, cardiovascular and cerebrovascular, diabetes, and amino acid categories. The company has an annual production capacity of 15,000 tons of various APIs, 6 billion tablets/capsules/sachets of oral solid preparations, and 2 billion vials of powder injections. The enterprise has passed ISO9001 Quality Management System Certification, ISO14001 Environmental Management System Certification, and OSHMS Occupational Health and Safety Management System Certification. Multiple API products have passed EU cGMP certification and US FDA certification. Lukang products sell well nationwide and are exported to more than 50 countries and regions in Asia, Europe, Africa, and the Americas, with an annual export value of 150 million US dollars.
Lukang Pharmaceutical has 4 national high-tech enterprises, 1 national enterprise technology center, 2 provincial enterprise technology centers, and 1 Shandong Provincial Engineering Technology Research Center. It has established academician workstations and post-doctoral research workstations. It is a "National Torch Plan Key High-tech Enterprise" and one of the first batch of "National Comprehensive New Drug R&D Technology Platform (Shandong) Industrialization Demonstration Enterprises". In 2018, it co-built the Shandong Biotechnology Industry Transformation Platform with the Tianjin Institute of Industrial Biotechnology of the Chinese Academy of Sciences. The Provincial Department of Science and Technology approved the establishment of the Shandong Brand International Science and Technology Cooperation Base, and the Shandong University-Lukang Pharmaceutical Microbiology Research Institute was established.
Lukang Pharmaceutical is a vice-chairman unit of the China Chemical Pharmaceutical Industry Association and the China Pharmaceutical Enterprise Management Association. It is a Top 100 Enterprise in China's Pharmaceutical Industry and a Top 100 Enterprise in China's Pharmaceutical Internationalization. It has received honors such as "National Advanced Enterprise for Quality and Efficiency", "Demonstration Enterprise for Drug Quality Integrity Construction", "National Outstanding Pharmaceutical Enterprise", "National Enterprise with Satisfied Customers", "MIIT 'Integration of Informatization and Industrialization' Benchmarking Pilot Enterprise", and "Benchmark Enterprise for 40 Years of Reform and Opening-up". The "Lukang" brand trademark has been rated as "Export Brand Key Cultivated and Developed by the Ministry of Commerce". In May 2019, the company was rated as a high-end brand cultivation enterprise in Shandong Province's manufacturing industry; in July, it was selected as one of the first batch of technological innovation demonstration enterprises in Shandong Province.
New era, new Lukang, new dreams, new future. Keeping humanity away from the pain of disease is the mission and unremitting pursuit of Lukang Pharmaceutical. With continuous investment in park construction, new drug R&D, product structure adjustment, and management improvement, Lukang will surely achieve leapfrog, high-quality, and sustainable development, making greater contributions to human health!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Lukang Pharmaceutical Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

Lukang Pharmaceutical Recruitment Overview / Current Status (5 open positions)

Manage
Note: How fast is hiring at Shandong Lukang Pharmaceutical Co., Ltd. growing? . A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Lukang Pharmaceutical Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 89,866.9632万(元)
Legal Representative: 彭欣
Date Established:
Credit Code: 913700001659297311
Registered Address: 山东省济宁高新区德源路88号

Partners & Suppliers

向四川百利药业提供抗生素类原料药 Source
合作客户 原料药供应
共建生物技术联合实验室,开展氨基酸发酵优化 Source
供应商 产学研合作
长治元延医药向鲁抗医药供应医药中间体。 Source
供应商 医药中间体
向蜀中药业(吉林)有限公司供应抗生素原料药 Source
合作客户 医药商业-分销
山东鲁抗医药为山东鲁盛制药提供头孢类原料药 Source
合作客户 原料药供应

People who follow Lukang Pharmaceutical also follow

Lukang Pharmaceutical Competitors (Similar Companies)

“Vice-President Unit of China Pharmaceutical Industry Association”
制药/药业 医药 医药中间体 原料药
粘胶 吊牌 卫生用品 无纺布
“Top 500 Chinese Enterprises”
“Providing first-class solutions for global new energy applications”
生物科技/生物工程 医药 医药中间体 化妆品原料
工程机械 推土机 机械制造 通用机械
“Biotechnology and bioactive materials”
生物科技/生物工程 医药 化妆品 透明质酸
“A globally important production and export base for antipyretic and an”
“Caring for life, safeguarding health”
“我们一起创造We make it together ”
“Helping partners successfully develop new drugs, reducing R&D costs an”
制药/药业 神经系统疾病药物 抗肿瘤药 抗生素
多肽 健康科技 新材料 纳米材料

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates